GlobeNewswire

Ossur Hf : Össur acquires College Park Industries

Share

Reykjavik, 19 July 2019

Össur has signed an agreement to acquire College Park Industries, a global provider of lower and upper limb prostheses and supporting services. College Park has over 140 employees and is headquartered in Detroit, USA. Total sales amounted to USD 22 million in 2018.

College Park will largely remain independent and continue to diligently serve its customer base, while allowing the combined entity to achieve strategic efficiencies. Össur is committed to growing the College Park brand over the coming years both in the United States and international markets. 

Together, both companies will be well-positioned to enhance their offerings in both lower and upper limb prosthetics. With this acquisition, Össur hopes to support College Park’s focus on the lower active population and further strengthen its established presence in the upper limb arena. Mutual access to technology and products will enable a more comprehensive product and service offering to customers around the world. This acquisition is yet another display of Össur’s commitment to elevating customer experience and improving people’s mobility.

The transaction will be financed through existing loan facilities and does not affect the existing share buyback program. Closing is expected later in 2019 subject to closing conditions and regulatory review. The acquisition will not have an impact on the financial guidance provided for the full year.

Jon Sigurdsson, President & CEO of Össur:

“College Park has created a strong brand presence over the past decades, recognized for its quality products and stellar service. It has also made important strides towards technology upgrade in the upper limb arena, an area where Össur hopes to support further development. We believe the joint efforts of the two brands will benefit our customers’ experience worldwide, all the while focusing on delivering the best solution for the end-user.”

Bill Carver, President & COO of College Park:

"We are very excited about Össur’s plans to strengthen the College Park brand. We look forward to becoming a part of the Össur organization and benefiting from some of the great innovation Össur is known for. We share the same vision of helping amputees live a life without limitations and ensuring superior service to our customers."

Further information

Jon Sigurdsson, President & CEO, +354 515 1300

Sveinn Solvason, CFO, +354 515 1300

David Hreidarsson, Investor Relations, dhreidarsson@ossur.com, +354 515 1380

Össur press releases by e-mail

If you wish to receive Össur press releases by e-mail please register at http://www.ossur.com/investors

About Össur

Össur (NASDAQ: OSSR) is a global leader in non-invasive orthopaedics that help people live a life without limitations. Its business is focused on improving people's mobility through the delivery of innovative technologies within the fields of braces, supports and prosthetic limbs. A recognized "Technology Pioneer", Össur invests significantly in research and product development; its award-winning designs ensuring a consistently strong position in the market. Successful patient and clinical outcomes are further empowered via Össur's educational programs and business solutions.  Headquartered in Iceland, Össur has major operations in the Americas, Europe and Asia, with additional distributors worldwide. www.ossur.com

About College Park Industries

College Park is an established global provider of broad and competitive prosthetic solutions. It has been well recognized for providing a varied portfolio of K2-K3 prosthetic feet, with the Truestep and Odyssey lines becoming frequent solutions clinicians reach out for. With its 2015 acquisition of Liberating Technologies, College park ventured into the upper limb arena with its first bionic product – the Espire Elbow launched in April 2019.  College Park is the 2018 recipient of the Hanger Service Excellence Award, a demonstration of its continued commitment to deliver unsurpassed customer service alongside competitive products. To learn more, visit www.college-park.com

About GlobeNewswire

GlobeNewswire
GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://globenewswire.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire

Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire

ObsEva SA to Hold Conference Call to Discuss PRIMROSE 2 Trial Results on December 9, 20196.12.2019 22:30:00 CETPress release

Geneva, Switzerland and Boston, MA –December 6, 2019 - ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies to improve women’s reproductive health, today announced that it will release results from the Phase 3 PRIMROSE 2 clinical trial of linzagolix for the treatment of heavy menstrual bleeding due to uterine fibroids, on Monday December 9, 2019. ObsEva management will host an investment community conference call at 8 a.m. Eastern Time, 2 p.m. Central European Time, Monday December 9, 2019, to discuss these results. Investors may participate by dialing (844) 419-1772 for U.S. callers or +1 (213) 660-0921 for international callers, and referring to conference ID 1764134. A webcast of the conference call can be accessed under the “Investors” section of ObsEva’s website www.obseva.com. About ObsEva ObsEva is a clinical-stage biopharmaceutical company focused on the clinical development and commercialization of novel therapeutics

OPENING OF A CALL FOR TENDER TO PROVIDE A CONTINUATION OR SALE PLAN IN THE FRAME OF REOGANIZATION PROCEEDINGS6.12.2019 17:45:00 CETPress release

COMMUNIQUE DE PRESSE · COMMUNIQUE DE PRESSE · COMMUNIQUE DE PRESSE OPENING OF A CALL FOR TENDER TO PROVIDE A CONTINUATION OR SALE PLAN IN THE FRAME OF REOGANIZATION PROCEEDINGS The deadline for submission of all tenders is January 10th, 2020 before 04:00pm Paris and Boston, December 6th, 2019 – 05h45pm CET - Neovacs (Euronext Growth Paris : ALNEV) announces the launch of a call for tender opened from now until January 10th, 2020 before 4:00 pm, to provide a continuation plan through partners or investors (articles L.626-1 and L.626-3 of the French Commercial code) or a sale plan by one or more buyers (Articles L.642-1 et seq. of the French Commercial Code). Candidates are invited to submit their offer before January 10th, 2020 at 04:00pm at the following law office: SELARL 2M and associates, to Maître Carole Martinez, judicial administrator, 22 rue de l'Arcade 75008 Paris, France. Email: a.dekoninck@aj-2m.com Access to information for auditing the company (electronic data room), will b

Conditions for Riksbank Bid Procedures Sek Bonds6.12.2019 16:20:00 CETPress release

Sveriges Riksbank Bid procedure details Government Bonds, 2019-12-12 Maturity date Loan ISIN code Coupon Volume, SEK million 2022-06-01 1054 SE0003784461 3.50 % 500 +/- 250 2029-11-12 1061 SE0011281922 0.75 % 500 +/- 250 Settlement date 2019-12-16 Bids have to be entered by 10.00 on DEC 12, 2019 Highest permitted bid volume: 500 SEK million in issue SGB 1054 and 500 SEK million in issue SGB 1061 Lowest permitted bid volume: 50 SEK million Bids only through counterparties approved by the Riksbank RESULT OF AUCTION WILL BE PUBLISHED NO LATER THAN 10.10 (CET) ON DEC 12, 2019. For more information, please contact: Trading desk at the Riksbank + 46 8 696 6970 General and special terms and conditions can be retrieved at http://www.riksbank.se

Result of AGM6.12.2019 16:15:00 CETPress release

6 December 2019 Volta Finance Limited (VTA / VTAS) RESULTS OF THE THIRTEENTH ANNUAL GENERAL MEETING Volta Finance Limited announces that at the Thirteenth Annual General Meeting held earlier today all resolutions proposed were duly passed. Two of these resolutions were special resolutions. The full text of the resolutions can be found in the Notice of Meeting contained with the Annual Report and Accounts 2019, copies of which are available for viewing at on the Company’s website http://www.voltafinance.com The Board notes the votes against the resolutions to approve the re-election of the directors, Graham Harrison, Stephen Le Page, Paul Meader, Atosa Moini and Paul Varotsis, contained in resolutions 4 to 8 inclusive. The votes against each resolution equate to 37.05% of the total voted by proxy. The Board, through the Chair, AXA Investment Manager and the Company’s corporate broker, seeks to maintain an ongoing dialogue with major shareholders, including dissenting shareholders, and w

Beter Bed Holding announces sale and lease-back of the distribution centers in Hoogeveen and Nieuw-Vennep6.12.2019 15:00:00 CETPress release

Highlights: Beter Beheer B.V., the wholly owned subsidiary of Beter Bed Holding, has entered into two separate sale-and-leaseback transactions for its properties in Hoogeveen and Nieuw-Vennep for a cash consideration of in total € 5.1 million. The total book profit on these transactions is circa € 1.6 million after tax. Together with the previously announced sale-and-leaseback transaction of the property in Uden (Linie 27), these transactions show that the Benelux operations of Beter Bed Holding will continue operating in its current logistical structure. These transactions contribute to the improvement of the net debt position of Beter Bed Holding, because the proceeds will be used to repay bank debt. Together with the divestment of Matratzen Concord that was completed on 2 December, these transactions are important steps for the transformation of Beter Bed Holding. John Kruijssen, CEO of Beter Bed Holding, comments: “With these sale-and-leaseback transactions and the divestment of Ma

Changes in ownership6.12.2019 14:43:00 CETPress release

06 December 2019 Changes in ownership Redbrick Investments S.a.r.l. (Luxemburg) increased its stake in PJSC Acron to 62.65% from 62.48% by purchasing shares from JSC Agronova that decreased its stake to 0.15%. Media contacts: Sergey Dorofeev Anastasiya Gromova Tatiana Smirnova Public Relations Phone: +7 (495) 777-08-65 (ext. 5196) Investor contacts: Ilya Popov Investor Relations Phone: +7 (495) 745-77-45 (ext. 5252) Background Information Acron Group is a leading vertically integrated mineral fertiliser producer in Russia and globally, with chemical production facilities in Veliky Novgorod (Acron) and the Smolensk region (Dorogobuzh). The Group owns and operates a phosphate mine in Murmansk region (North-Western Phosphorous Company, NWPC) and is implementing a potash development project in Perm Krai (Verkhnekamsk Potash Company, VPC). It owns transportation and logistics infrastructure, including three Baltic port terminals and distribution networks in Russia and China. Acron’s subsidi